Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

62.00p
   
  • Change Today:
      0.50p
  • 52 Week High: 119.60
  • 52 Week Low: 35.30
  • Currency: UK Pounds
  • Shares Issued: 540.14m
  • Volume: 417,457
  • Market Cap: £334.89m
  • RiskGrade: 119

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
72.49% below the market average72.49% below the market average72.49% below the market average72.49% below the market average72.49% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
1yr Revenue Growth
48.78% below the market average48.78% below the market average48.78% below the market average48.78% below the market average48.78% below the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
23.33% below the market average23.33% below the market average23.33% below the market average23.33% below the market average23.33% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
1yr DPS Growth
27.75% below the market average27.75% below the market average27.75% below the market average27.75% below the market average27.75% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
9.57% below the market average9.57% below the market average9.57% below the market average9.57% below the market average9.57% below the market average
31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average31.25% below the sector average
Price Book Ratio
12.79% below the market average12.79% below the market average12.79% below the market average12.79% below the market average12.79% below the market average
37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average37.93% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
46.4% below the market average46.4% below the market average46.4% below the market average46.4% below the market average46.4% below the market average
4.92% below the sector average4.92% below the sector average4.92% below the sector average4.92% below the sector average4.92% below the sector average
Price Chg 3m
29.1% below the market average29.1% below the market average29.1% below the market average29.1% below the market average29.1% below the market average
1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average1.64% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
24.47% above the market average24.47% above the market average24.47% above the market average24.47% above the market average24.47% above the market average
27.59% above the sector average27.59% above the sector average27.59% above the sector average27.59% above the sector average27.59% above the sector average
Momentum 20
43.14% below the market average43.14% below the market average43.14% below the market average43.14% below the market average43.14% below the market average
27.59% below the sector average27.59% below the sector average27.59% below the sector average27.59% below the sector average27.59% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
4.68% below the market average4.68% below the market average4.68% below the market average4.68% below the market average4.68% below the market average
40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average40.00% above the sector average
ROCE
14.34% above the market average14.34% above the market average14.34% above the market average14.34% above the market average14.34% above the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
10.70% above the market average10.70% above the market average10.70% above the market average10.70% above the market average10.70% above the market average
56.67% above the sector average56.67% above the sector average56.67% above the sector average56.67% above the sector average56.67% above the sector average
Forecast EPS
62.62% below the market average62.62% below the market average62.62% below the market average62.62% below the market average62.62% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
39.84% above the market average39.84% above the market average39.84% above the market average39.84% above the market average39.84% above the market average
55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average55.00% above the sector average
Operating Profit Loss
30.11% above the market average30.11% above the market average30.11% above the market average30.11% above the market average30.11% above the market average
76.67% above the sector average76.67% above the sector average76.67% above the sector average76.67% above the sector average76.67% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
43.12% above the market average43.12% above the market average43.12% above the market average43.12% above the market average43.12% above the market average
57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average57.89% above the sector average
Cash
40.70% above the market average40.70% above the market average40.70% above the market average40.70% above the market average40.70% above the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
24.06% below the market average24.06% below the market average24.06% below the market average24.06% below the market average24.06% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Brokers Percent Neutral
20.31% below the market average20.31% below the market average20.31% below the market average20.31% below the market average20.31% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 62.00p
Change Today 0.50p
% Change 0.81 %
52 Week High 119.60
52 Week Low 35.30
Volume 417,457
Shares Issued 540.14m
Market Cap £334.89m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.97% above the market average38.97% above the market average38.97% above the market average38.97% above the market average38.97% above the market average
73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average73.33% above the sector average
Price Trend
12.72% below the market average12.72% below the market average12.72% below the market average12.72% below the market average12.72% below the market average
8.20% above the sector average8.20% above the sector average8.20% above the sector average8.20% above the sector average8.20% above the sector average
Income
29.95% below the market average29.95% below the market average29.95% below the market average29.95% below the market average29.95% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Growth
90.46% below the market average90.46% below the market average90.46% below the market average90.46% below the market average90.46% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 01-Jun-2023

Time Volume / Share Price
16:37 10,000 @ 62.00p
16:35 61,810 @ 62.00p
16:35 22 @ 62.00p
16:35 120 @ 62.00p
16:35 200 @ 62.00p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Jo Le Couilliard

Top of Page